Previous close | 51.41 |
Open | 0.00 |
Bid | 51.75 x 0 |
Ask | 52.10 x 0 |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | 4,750 |
Market cap | 1.479T |
Beta (5Y monthly) | 0.56 |
PE ratio (TTM) | 48.41 |
EPS (TTM) | 1.07 |
Earnings date | 25 July 2024 - 29 July 2024 |
Forward dividend & yield | 1.45 (2.80%) |
Ex-dividend date | 12 Apr 2024 |
1y target est | N/A |
Insightful Analysis of AbbVie's Strengths, Weaknesses, Opportunities, and Threats
Eli Lilly (LLY), Novo Nordisk (NVO), Pfizer (PFE) and AbbVie (ABBV) announce their first-quarter results.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.